Earnings per share of BioNTech 2017-2023
In 2023, annual earnings per share of biotech company BioNTech SE stood at around 3.9 euros, compared to around 39 euros in 2022. This statistic illustrates the annual earnings per share of BioNTech SE from 2017 to 2023. On November 9th 2020, German biotech company BioNTech in cooperation with U.S. pharma giant Pfizer were the first to announce a proven COVID-19 vaccine to be ready for mass production by year-end.